Home | AI powered stock trade ideas | Market Signals | Breaking Out | New Green Signal Stocks | Recent Red Arrow Top Signals | Recent Green Arrow Bottom Signals | Near Term Bottom Signals | Green Stocks with Most Upside to Analyst Target Price | New Long Term Green AI Signals | Big Tech Stocks | ETF Sector SPDRs | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals | Mining Stocks | Free AI Portfolio Analyzer | How to Read and Trade AI Powered Stock Charts| Stock Charts AI top 50 Stocks

Recently Featured Stock Charts
86% AI Stock Prediction Accuracy
Enter Stock Symbol to View AI powered Stock Chart

StockChartsAI.com

All Chart Prices Delayed at least 15 minutes

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.

Last Price: 51.73 - Change: 2.05 - Change %: 4.1264
05/24/2024 16:00:00 EST

Tandem Diabetes Care Inc (TNDM)

Industry: Medical Devices

Price Support Resistance

In the past 20 trading days, TNDM has been trading in a range between $49.32 and $36.20 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

TNDM is breaking above top of the recent 20 day range at $49.32 and appears that it could have some more upside. If it enters a yellow zone the trend may be faltering - consider exiting or taking profits. If it enters a red zone on the chart we would exit the position.

Upside / Downside Potential

Tandem Diabetes Care Inc $TNDM entered a Green zone 25 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $39.33, a potential down side of -20.83% from the recent price of 49.68. The stock is trading 5.7% (potential upside) below its 52 week high of $52.51 and 259.48 % (potential downside) above its 52 week low of $13.82 - based on the recent price.

Company Summary

Tandem Diabetes Care, Inc, a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system.

TNDM Website

News

Tandem Diabetes Care Announces Upcoming Conference Presentation
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 8:00am Eastern Time (5:00am Pacific Time). The Company update presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes.
Source: Business Wire
Thu, 23 May 2024 16:05:00 -0400
Sentiment: Neutral
Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?
Tandem Diabetes (TNDM) outperforms the industry, owing to its impressive series of product launches and an impressive quarterly performance.
Source: Zacks Investment Research
Fri, 17 May 2024 10:46:16 -0400
Sentiment: Positive
Why Tandem Diabetes Stock Just Jumped 22%
Tandem Diabetes Care beat earnings -- but only by losing less money than expected -- on Thursday. On the plus side, sales jumped much higher than expected.
Source: The Motley Fool
Fri, 03 May 2024 16:34:00 -0400
Sentiment: Positive
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
Tandem Diabetes (TNDM) outperforms in the first quarter, backed by the demand for both t:slim X2 and the newly launched Tandem Mobi.
Source: Zacks Investment Research
Fri, 03 May 2024 10:36:15 -0400
Sentiment: Neutral
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal
Tandem Diabetes stock rocketed Friday after the insulin pump-maker topped first quarter expectations. But DaVita stock reversed lower.
Source: Investors Business Daily
Fri, 03 May 2024 10:20:07 -0400
Sentiment: Positive
Instituions Institution %: 117.068
Last QTR Institution change: 33858

Insiders
Insiders %: 0.704
Insiders Purchases last QTR: 14135
Insiders Sales last QTR: 0
Insiders Net last QTR: 14135

Analyst Ratings
Target Price: 39.33
Overall Rating: 3.875
Strong Buys (5): 7
Buys (4): 2
Holds (3): 5
Sells (2): 2
Strong Sells (1): 0

Technicals
52 Week Hi: 52.51
52 Week Low: 13.82
Beta: 1.104
50 Day MA: 37.5444
200 Day MA: 27.0366

Earnings / Revenue Trends
Qtr Earnings Growth YOY: -0.37
Qtr Revenue Growth YOY: 0.132
Forward PE: 1111.1111
Trailing PE: 0

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!

1000

Stock Analyzed Each Night

Portfolio

Easily Upload Track Your Stocks

Trends

See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.